Yesterday's "bad" news from Novo Nordisk came from its Phase 3 trials of oral semaglutide in the early stage of Alzheimer's disease. The trials did not establish the superior efficacy of oral ...
Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...
Women who use GLP-1 ‘fat jabs’ too close to becoming pregnant may face higher risk of complications, new study says.
Novo Nordisk A/S is rated a Strong Buy with a huge unmet demand in obesity treatment and a low 13x P/E ratio. Learn more ...
Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...
Novo Nordisk reported promising mid-stage results for its experimental obesity drug amycretin in diabetes patients on Tuesday ...
Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still asking if GLP-1 drugs ...
Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online ...
Keep an eye on Novo Nordisk: Trump struck a deal with drugmakers Eli Lilly and Novo Nordisk earlier this month for their ...
EASTENDERS star Lorraine Stanley looks incredible while showing off her six stone weight loss in a plunging dress. Lorraine, ...
Vascular dementia is the second-most common form of dementia after Alzheimer's. About 2.7 million people in the U.S. are thought to have mixed dementia or vascular dementia, which is caused by strokes ...
Michelle Obama’s new photoshoot showing a slimmer look sparked online speculation about her using Ozempic. The diabetes drug, often linked to weight loss, is not FDA-approved for slimming. There’s no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback